TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation

TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation

<i>TP53</i> mutations are associated with extremely poor outcomes in acute myeloid leukemia (AML). The outcomes of patients with <i>TP53</i>-mutated (<i>TP53</i><sup>MUT</sup>) AML after different frontline treatment modalities are not well established...

Full description

Bibliographic Details
Main Authors: Davidson Zhao, Mojgan Zarif, Qianghua Zhou, José-Mario Capo-Chichi, Andre Schuh, Mark D. Minden, Eshetu G. Atenafu, Rajat Kumar, Hong Chang
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
<i>TP53</i>
next-generation sequencing
AML
transplantation
Online Access:https://www.mdpi.com/2072-6694/15/12/3210

Internet

https://www.mdpi.com/2072-6694/15/12/3210

Similar Items